Search

Your search keyword '"Susan A. Melin"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Susan A. Melin" Remove constraint Author: "Susan A. Melin" Topic cancer research Remove constraint Topic: cancer research
37 results on '"Susan A. Melin"'

Search Results

1. Abstract PD1-04: Results of a phase II double-blinded, randomized, placebo-controlled clinical trial of Indoximod, an Indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor, in combination with Taxane chemotherapy in metastatic breast cancer (MBC)

2. Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor

Catalog

Books, media, physical & digital resources

3. Abstract P1-08-03: An early look at incidence and survival by HR and HER2 status among young US women with stage I-III breast cancer: SEER 2010-15

4. Abstract P1-17-04: Long-term safety follow-up of patients with early stage breast cancer treated with scalp cooling on the Dignitana scalp cooling trial

5. Machine learning models for accurate pretreatment prediction of chemotherapy associated LV dysfunction in patients with breast cancer and lymphoma receiving chemotherapy (WF-98213 PREVENT and CCCWFU9912 DETECT IV)

6. Randomized trial of atorvastatin during and following receipt of doxorubicin for breast cancer and lymphoma (WF-98213)

7. Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial

8. A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer

9. Incidence and Survival by Human Epidermal Growth Factor Receptor-2 Status in Young Women with Stage I-III Breast Cancer: SEER 2010–2016

10. Abstract P5-11-17: Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced alopecia

11. Abstract P5-10-02: African Americans have more aggressive invasive lobular carcinoma subtypes and inferior early outcomes: SEER 2010-2013

12. Abstract PS13-02: Global myocardial perfusion is reduced in premenopausal breast cancer patients treated with ovarian function suppression and aromatase inhibitor therapy: An adenosine stress T1 map CMR study

13. Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

14. Disparities in HER2 testing in breast cancer

15. Non-invasive assessment of chemotherapy-induced peripheral neuropathy using neuromuscular ultrasound in breast cancer patients

16. Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer

17. Abstract P2-12-11: Use of the DigniCap™ System to Prevent Hair Loss in Women Receiving Chemotherapy (CTX) for Stage I Breast Cancer (BC)

18. Failure to Apply Eligibility Criteria per CALGB 9343 When Omitting Radiation Therapy Results in Excess Locoregional Failures in Elderly Breast Cancer Patients

19. Neuromuscular ultrasound for assessment of peripheral neuropathy in breast cancer patients receiving taxane therapy

20. A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

21. A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer

22. Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study

23. A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer

24. Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer

25. Aortic stiffness increases upon receipt of anthracycline chemotherapy

26. Clinical performance of the DigniCap system, a scalp hypothermia system, in preventing chemotherapy-induced alopecia

27. Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

28. Toxicity and preliminary results from a trial of hyperfractionated radiation with or without simultaneous 5-fluorouracil-cisplatin in advanced head and neck squamous cell carcinomas

29. Pre-operative hyperfractionated radiotherapy and concurrent 5-fu/cisplatin for locally advanced esophageal cancer - the impact of 18-F-fluoro-deoxy-d-glucose (FDG) positron emission tomography staging

30. Phase II trial of gemcitabine and concurrent radiation for the treatment of resected pancreatic cancer

31. Clinical performance, efficacy, and safety of the DigniCap system, a scalp-hypothermia system, in preventing chemotherapy (CTX)-induced alopecia in patients (pts) with early-stage breast cancer (BC)

32. Self-reported compliance compared to biomarker levels of vitamin E in breast cancer patients participating in a CoQ10 clinical trial

33. Patterns of Failure for Esophageal Cancer Patients Optimally Staged With 18-F-FDG-PET and Observed After Chemo-radiotherapy

34. Tri-Modality Therapy for Esophageal Cancer: Mucinous Histology Is Associated With Decreased Pathologic Response Rates to Neoadjuvant Chemoradiation Therapy

35. [Untitled]

36. Pre-operative hyperfractionated radiotherapy and concurrent 5-FU/cisplatin for locally advanced esophageal cancer - the impact of 18-F-fluoro-deoxy-D-glucose (FDG) positron emission tomography staging

37. Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study